Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Health Sciences Acquisitions Corp 2 | Chief Executive Officer, Director, 10%+ Owner | Ordinary Shares | 2.81M | $45M | $16.04 | Jan 24, 2023 | Indirect |
ROCKET PHARMACEUTICALS, INC. | Director, 10%+ Owner | Stock Option (Right to Buy) | 3.33K | $50K | $15.04 | Jun 13, 2024 | Direct |
Avidity Biosciences, Inc. | Director, 10%+ Owner | Stock Option (Right to Buy) | 15K | Jun 16, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RCKT | ROCKET PHARMACEUTICALS, INC. | Jun 13, 2024 | 2 | $50K | 4 | Jun 20, 2024 | Director, 10%+ Owner |
RCKT | ROCKET PHARMACEUTICALS, INC. | Jun 22, 2023 | 2 | $50K | 4 | Jun 26, 2023 | Director, 10%+ Owner |
OBIO | Health Sciences Acquisitions Corp 2 | Jan 24, 2023 | 1 | $18.1M | 4 | Jan 26, 2023 | Chief Executive Officer, Director, 10%+ Owner |
OBIO | Health Sciences Acquisitions Corp 2 | Jul 22, 2022 | 1 | $10M | 4 | Jul 25, 2022 | Chief Executive Officer, Director |
RCKT | ROCKET PHARMACEUTICALS, INC. | Jun 13, 2022 | 2 | $40K | 4 | Jun 15, 2022 | Director, 10%+ Owner |
RCKT | ROCKET PHARMACEUTICALS, INC. | Aug 27, 2021 | 1 | $26.4M | 4 | Aug 31, 2021 | Director, 10%+ Owner |
RNA | Avidity Biosciences, Inc. | Jun 16, 2021 | 1 | $0 | 4 | Jun 17, 2021 | Director, 10%+ Owner |
RCKT | ROCKET PHARMACEUTICALS, INC. | Jun 14, 2021 | 1 | $0 | 4 | Jun 16, 2021 | Director, 10%+ Owner |